In patients who are event-free after 3-6 months of DAPT and who are not at high ischaemic risk, what change in antithrombotic therapy…

…Based on available data regarding patients who develop anthracycline-induced cardiomyopathy, what is the expected outcome following the initiation of beta-blockers and angiotensin-converting…

…SCD) to determine its suitability for identifying patients who may benefit from an implantable cardioverter-defibrillator (ICD). Which of the following methodological characteristics represents a…

…SVT. Compared to SVT patients who have underlying cardiovascular disease, which of the following clinical characteristics is most likely to be observed in this patient…

…a professional athlete who wishes to avoid lifelong oral anticoagulation and is inquiring about alternatives to a mechanical heart valve. Which of the following is…

…who is a known alcoholic, is brought in by his friends for sudden onset of severe chest pain and vomiting after a heavy drinking session…

…thrombotic agent in patients undergoing percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS). The primary safety endpoint is the incidence of post-procedural myocardial…

…Which of the following intravenous medications has been evaluated for termination of sustained monomorphic VT in patients with coronary artery disease with or without healed…

A patient's ECG shows intermittently non-conducted P waves with a fixed PR interval. What type of AV block does this describe, and what…

This 54-year-old patient with Covid-19 (Sars-Cov-2) has a slightly irregular rhythm. What is the rhythm and should you be concerned…

A 64 year old male patient with hypertension. ECG is recorded during his annual health screening. He is asymptomatic during the recording. Heart rate 67…

…The patient experiences palpitations with sudden onset and occassionally the sensation that the heart skips a beat. Clinical examination reveals nothing suspicious and the patient…